Craft

Envision Pharma Group

Revenue

$153.2 M

FY, 2020

Envision Pharma Group Summary

Company Summary

Overview
Envision Pharma Group is a company that provides medical affairs and healthcare communications services. It offers technology solutions such as iEnvision, a web-based platform for pharmaceutical product life cycle management; Datavision, a tool for publication management and reporting; doDOC, a suite for collaborative review; etc. The company also provides medical strategy, patient engagement, publication planning and delivery, medical communications, and other services.
Type
Subsidiary
Status
Active
Founded
2001
HQ
Horsham, GB | view all locations
Website
https://www.envisionpharmagroup.com/
Cybersecurity rating
Sectors

Key People

  • Howard Miller

    Howard Miller, Chief Executive Officer

  • Dominic Marasco

    Dominic Marasco, Executive President and Cheif Commercial Officer

  • Paul Archer

    Paul Archer, Chief Commercial Strategy Officer

  • Joshua Korth

    Joshua Korth, Chief Financial Officer

Operating MetricsView all

Products

3

Dec, 2023

Therapeutic Areas

30

Dec, 2023

Solutions

4

Dec, 2023

LocationsView all

14 locations detected

  • Horsham, England HQ

    United Kingdom

    Envision House, 5 North St

  • Fairfield, CT

    United States

    75 Kings Hwy Cutoff 2nd floor

  • Johnson City, TN

    United States

    208 Sunset Dr

  • Powell, OH

    United States

    110 Riverbend Ave #100

  • Macquarie Park, NSW

    Australia

    Kuring-gai, Suite 1.01, Talavera Business Park, Level 1, 6-10 Talavera Road

  • Szeged

    Hungary

    Maros utca 43

and 8 others

Envision Pharma Group Financials

Summary Financials

Net income (FY, 2022)
($26.0M)
EBIT (FY, 2022)
$11.0K

Footer menu